Koya Medical announces positive interim results from randomized controlled study of Dayspring active compression treatment for lymphedema and venous disease.
Positive Interim Results for Dayspring Lymphedema Treatment Read More »
Koya announces the grand opening of its new headquarters in Dallas, TX as the company scales to meet rising demand for its breakthrough therapies.
Koya Medical Opens New Dallas HQ to Power Next Phase of Growth in Vascular Health Read More »
SecondWave Systems, Inc., a pioneer in the emerging field of bio-ultrasonic medicine, today announced completion of a pilot clinical study evaluating its nov…
/PRNewswire/ — SecondWave Systems, Inc., a clinical stage medical device company developing a novel ultrasound-based treatment for inflammatory disorders,…
Using Mind.Px™ test results, altered physician prescribing behavior leads to faster,more effective patient outcomes Vista, CA, May 13, 2025 (GLOBE NEWSWIRE) Mindera Health, a leader in precision medicine for dermatological conditions, today announced positive results from the completion of a randomized, prospective clinical trial (MATCH) aimed at demonstrating the clinical utility of Mind.Px™, the first
Podimetrics partners with HealthMed to expand access to its SmartMat Program, a diabetes solution that enhances chronic care management
DAV Magazine Features SmartMat in Veteran Diabetes Care Spotlight Read More »
Podimetrics partners with HealthMed to expand access to its SmartMat Program, a diabetes solution that enhances chronic care management
San Diego, CA, July 31, 2024 (GLOBE NEWSWIRE) — Mindera Health Inc. announces the closing of a $14M convertible note financing, led by Mountain Group Partners and other existing investors in anticipation of a Series B financing in 2025. Proceeds will support the continued commercialization of Mindera’s lead product, Mind.Px™. “This capital raise will fuel